Prostate Cancer - Results from #400

PARP inhibitors alone or in combination for prostate cancer. August 30, 2024

Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database. August 29, 2024

RAD21 promotes oncogenesis and lethal progression of prostate cancer. August 29, 2024

Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer. August 29, 2024

5-α Reductase Inhibitors and Prostate Cancer Mortality. August 29, 2024

Mortality from prostate cancer in the years 2007-2021 in North Rhine-Westphalia, Germany. August 29, 2024

Appropriateness of Imaging for Low-Risk Prostate Cancer-Real World Data from the Pennsylvania Urologic Regional Collaboration (PURC). August 29, 2024

Prior Negative Biopsy, PSA Density, and Anatomic Location Impact Cancer Detection Rate of MRI-Targeted PI-RADS Index Lesions. August 29, 2024

Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center. August 28, 2024

Barriers and facilitators of the application of precision medicine to the genitourinary cancer care pathway: Perspective from a low- and middle- income country in sub-Saharan Africa. August 28, 2024

The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigue. August 28, 2024

Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care. August 28, 2024

18F-Flotufolastat Positron Emission Tomography in African American Patients With Suspected Prostate Cancer Recurrence: Findings From the Phase 3 SPOTLIGHT Study. August 28, 2024

Neighborhood greenness and long-term physical and psychosocial quality of life among prostate cancer survivors in the Health Professionals Follow-up Study. August 28, 2024

Proficiency score as a predictor of early trifecta achievement during the learning curve of robot-assisted radical prostatectomy for high-risk prostate cancer: Results of a multicentric series. August 27, 2024

DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes. August 27, 2024

Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses. August 27, 2024

Epigenetic profiling of prostate cancer reveals potential prognostic signatures. August 27, 2024

The learning curve for transperineal MRI/TRUS fusion prostate biopsy: A prospective evaluation of a stepwise approach. August 27, 2024

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases. August 27, 2024

Page 21 of 1438